bosentan anhydrous has been researched along with Obesity in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoepf, TM; Holycross, BJ; McCune, SA; Radin, MJ | 1 |
Bang, WD; Chang, HJ; Cho, SS; Jang, JY; Joung, B; Kim, JY; Oh, CM; Yu, HT | 1 |
2 other study(ies) available for bosentan anhydrous and Obesity
Article | Year |
---|---|
Salt-induced cardiac hypertrophy is independent of blood pressure and endothelin in obese, heart failure-prone SHHF rats.
Topics: Animals; Base Sequence; Blood Pressure; Bosentan; Cardiomegaly; DNA Primers; Endothelin Receptor Antagonists; Endothelins; Gene Expression; Heart Failure; Leptin; Male; Nitric Oxide Synthase; Obesity; Rats; RNA, Messenger; Sodium Chloride, Dietary; Sulfonamides | 2008 |
Pulmonary hypertension associated with use of phentermine.
Topics: Adult; Antihypertensive Agents; Bosentan; Electrocardiography; Female; Humans; Hypertension, Pulmonary; Models, Chemical; Obesity; Phentermine; Radiography, Thoracic; Safety; Sulfonamides | 2010 |